ADC Therapeutics SA
ADCT
$3.43
-$0.05-1.44%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -414.40% | 84.36% | 27.68% | -46.74% | -25.63% |
| Total Depreciation and Amortization | 0.88% | -7.38% | -85.48% | 83.01% | -42.12% |
| Total Amortization of Deferred Charges | -8.54% | -66.44% | 12.77% | 240.31% | 134.29% |
| Total Other Non-Cash Items | 158.72% | -233.75% | -35.83% | 41.22% | 902.09% |
| Change in Net Operating Assets | 56.78% | -3,053.83% | -97.45% | 152.00% | -394.36% |
| Cash from Operations | 4.54% | -5.04% | -23.01% | 57.24% | -157.80% |
| Capital Expenditure | -- | -- | -- | 100.00% | -193.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -104.86% | -- | -- | 100.00% | -193.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.65% | -- | -- | 34,598.52% | 530.23% |
| Repurchase of Common Stock | 39.24% | -538.38% | 20.80% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.02% | 28,932.83% | -100.21% | 34,506.27% | 124.20% |
| Foreign Exchange rate Adjustments | 80.00% | -516.67% | -96.32% | 1.24% | 146.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -214.02% | 189.20% | -142.69% | 224.38% | -139.97% |